In an innovative mouse model for melanoma, researchers observed that treatment with anti-PD-1 therapy resulted in the infiltration of CD4+ and CD8+ T cells into the myocardium, with a notable increase in activation level for the latter. Here, PDCD1 is linked to melanoma.